Royal Prima PT (PRIM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, Royal Prima PT (PRIM) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.86 Billion ≈ $108.71K USD) by net assets (Rp955.60 Billion ≈ $55.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Royal Prima PT balance sheet quality to measure how much of total assets are equity-financed.

Royal Prima PT - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Royal Prima PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Royal Prima PT earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Royal Prima PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Royal Prima PT ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Magna Finance Tbk
JK:MGNA
-0.020x
Resverlogix Corp.
TO:RVX
0.011x
Kumbi Corporation
KO:008870
0.059x
KR1 PLC LS -0019
F:K4H
N/A
Diamond Citra Propertindo PT
JK:DADA
0.016x
Cherrybro co.Ltd
KQ:066360
0.064x
Daishin Information & Communications Co.Ltd
KQ:020180
-0.060x
Victor Group Holdings Ltd
AU:VIG
0.072x

Annual Cash Flow Conversion Efficiency for Royal Prima PT (2014–2024)

The table below shows the annual cash flow conversion efficiency of Royal Prima PT from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Royal Prima PT market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp962.38 Billion
≈ $56.39 Million
Rp46.98 Billion
≈ $2.75 Million
0.049x +125.21%
2023-12-31 Rp981.10 Billion
≈ $57.49 Million
Rp21.27 Billion
≈ $1.25 Million
0.022x -1.33%
2022-12-31 Rp982.66 Billion
≈ $57.58 Million
Rp21.59 Billion
≈ $1.27 Million
0.022x -90.97%
2021-12-31 Rp964.21 Billion
≈ $56.50 Million
Rp234.54 Billion
≈ $13.74 Million
0.243x +259.56%
2020-12-31 Rp889.35 Billion
≈ $52.11 Million
Rp60.16 Billion
≈ $3.53 Million
0.068x +1830.15%
2019-12-31 Rp851.17 Billion
≈ $49.88 Million
Rp2.98 Billion
≈ $174.81K
0.004x -91.58%
2018-12-31 Rp848.87 Billion
≈ $49.74 Million
Rp35.33 Billion
≈ $2.07 Million
0.042x -53.08%
2017-12-31 Rp250.42 Billion
≈ $14.67 Million
Rp22.22 Billion
≈ $1.30 Million
0.089x -96.16%
2016-12-31 Rp12.13 Billion
≈ $710.64K
Rp28.02 Billion
≈ $1.64 Million
2.310x +135.31%
2015-12-31 Rp722.89 Million
≈ $42.36K
Rp-4.73 Billion
≈ $-277.14K
-6.543x -274.24%
2014-12-31 Rp-2.10 Billion
≈ $-123.29K
Rp3.68 Billion
≈ $215.54K
-1.748x --

About Royal Prima PT

JK:PRIM Indonesia Medical Care Facilities
Market Cap
$21.78 Million
Rp371.62 Billion IDR
Market Cap Rank
#24829 Global
#523 in Indonesia
Share Price
Rp110.00
Change (1 day)
-2.65%
52-Week Range
Rp62.00 - Rp113.00
All Time High
Rp1640.00
About

PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more